Chris Viehbacher

crown royalty king queen win
Biotech

Biogen taps Royalty for $250M to fund phase 3 lupus program

The cash will bankroll phase 3 development of a lupus candidate that Biogen has named in a bunch of assets with potential peak sales of $14 billion.
Nick Paul Taylor Feb 12, 2025 8:10am
illustration of two people putting puzzle pieces together merger and acquisition concept

Biogen inks $1.15B HI-Bio buyout to expand in immunology

May 22, 2024 8:24am
brain alzheimers dementia neuroscience gears thought think

To be better at neuroscience, Biogen will invest elsewhere

Apr 24, 2024 10:37am
Graphic of someone identifying a candidate out of a crowd using a magnifying class

New Biogen research chief aims to add biotech hustle to pharma

Oct 10, 2023 10:50am
Alice in Wonderland tea party cup key clock watch

Biogen's tight-lipped zuranolone remarks disquiet Sage investors

Jul 26, 2023 10:45am